Highbridge Capital Management’s Avidity Biosciences RNAM Stock Holding History

Highbridge Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-585,550	Closed	-$42.2M	–	402
2025 Q4	$42.2M	Buy	+585,550	New	+$37.8M	1.35%	23

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Highbridge Capital Management's RNAM Position: Q1 2026 in Review

Highbridge Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 585,550 shares — an estimated $42.2M sold.

Highbridge Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $42.2M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Highbridge Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Highbridge Capital Management sold 585,550 Avidity Biosciences shares in Q1 2026, an estimated $42.2M.
Highbridge Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Highbridge Capital Management's Avidity Biosciences position peaked at $42.2M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Highbridge Capital Management's 13F filing for Q1 2026, filed 15 May 2026.